How the Catheter-Related Bloodstream Infection Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theCatheter-Related Bloodstream Infection Market from 2025 to 2034?
The catheter-related bloodstream infection market is anticipated to experience growth due to the escalating rate of hospital-acquired infections (HAIs). HAIs are a type of infection that a patient acquires while being treated for a different ailment within a healthcare facility, usually appearing 48 hours or more post admission. A multitude of factors including antimicrobial resistance, insufficient measures to control infection, and vulnerability of the patient are attributable to the raise in hospital-acquired infections. Catheter-related bloodstream infections present a significant part of hospital-acquired infections due to their invasive characteristic and the chance for microbial colonization, thus exposing patient with indwelling catheters to risk. For example, per the records of the National Library of Medicine, a biomedical library based in the U.S., in January 2023, the worldwide rate of healthcare-associated infection (HAI) stood at 0.14%, reflecting an annual increase of 0.06%. Hence, the escalating rate of hospital-acquired infections is predicted to spur the growth of the catheter-related bloodstream infection market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16646&type=smp
What is the Predicted Annual Growth Rate of theCatheter-Related Bloodstream Infection Market Impact Industry Trends by 2034?
The market size of catheter-related bloodstream infection has shown impressive expansion in the past years. It is set to escalate from $1.53 billion in 2024 to $1.62 billion in 2025, representing a compound annual growth rate (CAGR) of 6.2%. The upsurge during the historical period was driven by factors such as a growing number of chronic disease cases, heightening awareness and education about these infections, an increase in infections acquired in hospitals, swelling elderly population, and improved infection control courses in hospitals and healthcare environments.
Anticipated robust expansion is on the horizon for the catheter-related bloodstream infection market. Projections suggest a swelling to $2.05 billion by 2029, underpinned by a compound annual growth rate (CAGR) of 6.0%. The expected growth during this period can be credited to factors such as an upsurge in healthcare-associated infections (hais), amplified awareness and education, improved training programs centered on infection control protocols, enlargement of healthcare facilities, a rise in the elderly population, and beneficial governmental interventions and policies. Trends predicted to dominate the forecast period comprise of advancements in biomaterials, intelligent catheter technology, the creation of superior catheter lock solutions with progressive antimicrobial attributes, enhancements in catheter sterilization procedures, and the introduction of automated flushing practices.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16646
How Are Market Trends and Innovations Revolutionizing theCatheter-Related Bloodstream Infection Industry in Recent Times?
Key players in the catheter-related bloodstream infection market are focusing on the creation of innovative catheter lock solutions to increase infection prevention and augment patient outcomes. Catheter lock solutions are liquids used in catheters to inhibit infections and help in maintaining catheter patency when not in use. For example, in November 2023, CorMedix Inc., a biopharmaceutical firm located in the US that specializes in the development and commercialization of therapeutic products, got the green light from the US Food and Drug Administration to use DefenCath (taurolidine and heparin) catheter lock solution for adult patients suffering from kidney failure who are undergoing chronic hemodialysis via central venous catheter (CVC). This solution, which possesses antifungal and antimicrobial properties, is specifically designed to decrease catheter-related bloodstream infections (CRBSIs). It combines heparin for anticoagulation with taurolidine’s wide-ranging antimicrobial capabilities.
Which Key Market Players Are Shaping the Future and Growth of theCatheter-Related Bloodstream Infection Market?
Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Catheter-Related Bloodstream Infection Market, and How Do They Contribute to Growth?
The catheter-related bloodstream infection market covered in this report is segmented –
1) By Treatment: Antibiotic Lock Therapy, Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus, Acinetobacter Baumannii, Escherichia Coli (E. Coli), Klebsiella Pneumoniae (K. Pneumonia), Candida Species (Candida Sp.), Pseudomonas Aeruginosa (P. Aeruginosa), Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Antibiotic Lock Therapy: Catheter Lock Solutions (Antibiotic-based), Combination Antibiotic Lock Therapy
2) By Anti-Microbial Agents: Antibiotics, Antifungal Agents, Antiseptic Agents
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=16646&type=smp
What Regions Are Dominating the Catheter-Related Bloodstream Infection Market Growth?
North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Catheter-Related Bloodstream Infection Market 2025, By The Business Research Company:
PTA Balloon Catheter Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report
Intravascular Catheters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report
Intermittent Catheters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intermittent-catheters-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
